Neurology Clinical Trials Market by Phase (Phase I, Phase II, Phase III, and Phase IV), Study Design (Interventional, Observational, and Expanded Access), Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, and Others), and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032
Industry: Life Sciences | Report Code: LI23119048 | Pages: NA | Tables: NA | Upcoming Date : Oct 2023 |
- + 1-888-961-4454 Toll - Free
- +1 (917) 444-1262 - U.S
- + 91 7888029103 -Int'l
- support@researchdive.com